KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Other Operating Expenses: 2015-2024

Historic Other Operating Expenses for Acadia Pharmaceuticals (ACAD) over the last 10 years, with Dec 2024 value amounting to $146.5 million.

  • Acadia Pharmaceuticals' Other Operating Expenses rose 14.80% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.9 million, marking a year-over-year decrease of 179.48%. This contributed to the annual value of $146.5 million for FY2024, which is 251.88% up from last year.
  • According to the latest figures from FY2024, Acadia Pharmaceuticals' Other Operating Expenses is $146.5 million, which was up 251.88% from $41.6 million recorded in FY2023.
  • Acadia Pharmaceuticals' 5-year Other Operating Expenses high stood at $146.5 million for FY2024, and its period low was $10.2 million during FY2022.
  • Over the past 3 years, Acadia Pharmaceuticals' median Other Operating Expenses value was $41.6 million (recorded in 2023), while the average stood at $66.1 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Other Operating Expenses crashed by 46.89% in 2022 and then skyrocketed by 309.58% in 2023.
  • Acadia Pharmaceuticals' Other Operating Expenses (Yearly) stood at $20.6 million in 2020, then dropped by 6.86% to $19.1 million in 2021, then crashed by 46.89% to $10.2 million in 2022, then spiked by 309.58% to $41.6 million in 2023, then skyrocketed by 251.88% to $146.5 million in 2024.